Oral anticoagulation for secondary prevention after myocardial infarction with special reference to the warfarin re-infarction study.
Jafri
S M
SM
Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI 48202.
Gheorghiade
M
M
Goldstein
S
S
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014859:Warfarin